Literature DB >> 15825309

Interaction of clindamycin and gentamicin in vitro.

R J Fass, C A Rotilie, R B Prior.   

Abstract

The minimal inhibitory concentrations of clindamycin and gentamicin alone and in combinations were determined by a microdilution method for 163 aerobic, facultative, and anaerobic clinical isolates. All 77 strains of Staphylococcus aureus, Diplococcus pneumoniae, Streptococcus pyogenes, and anaerobic bacteria (except for three strains of Clostridium) were inhibited by 1.6 mug or less of clindamycin per ml. Gentamicin did not interfere with the activity of clindamycin within the range of concentrations tested (0.1 to 100 mug/ml); for some strains combinations were synergistic. Sixty-two (94%) of 66 strains of Enterobacteriaceae and Pseudomonas aeruginosa were inhibited by 6.2 mug or less of gentamicin per ml. Combinations of clindamycin and gentamicin were indifferent for 29 strains and synergistic for 33 strains. All 20 strains of enterococcus, three strains of Clostridium, three strains of Escherichia coli, and one strain of Proteus rettgeri were resistant to both clindamycin (minimal inhibitory concentration greater than 3.1 mug/ml) and gentamicin (minimal inhibitory concentration greater than 6.2 mug/ml). Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. Except for clindamycin-sensitive isolates, synergy was usually observed only at concentrations of one or both drugs which are not readily obtainable in vivo. Antagonism was never observed.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 15825309      PMCID: PMC444696          DOI: 10.1128/AAC.6.5.582

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  Clindamycin in the treatment of serious anaerobic infections.

Authors:  R J Fass; J F Scholand; G R Hodges; S Saslaw
Journal:  Ann Intern Med       Date:  1973-06       Impact factor: 25.391

Review 2.  Gentamicin.

Authors:  C E Cox
Journal:  Med Clin North Am       Date:  1970-09       Impact factor: 5.456

3.  Gentamicin treatment of staphylococcal infections.

Authors:  F Richards; C McCall; C Cox
Journal:  JAMA       Date:  1971-02-22       Impact factor: 56.272

4.  Antibiotic disc susceptibility tests for rapid presumptive identification of Gram-negative anaerobic bacilli.

Authors:  V L Sutter; S M Finegold
Journal:  Appl Microbiol       Date:  1971-01

5.  Clindamycin: clinical and laboratory evaluation of parenteral therapy.

Authors:  R J Fass; S Saslaw
Journal:  Am J Med Sci       Date:  1972-05       Impact factor: 2.378

  5 in total
  18 in total

1.  Simplified method for antimicrobial susceptibility testing of anaerobic bacteria.

Authors:  R J Fass; R B Prior; C A Rotilie
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

2.  Antibiotic-impregnated heart valve sewing rings for treatment and prophylaxis of bacterial endocarditis.

Authors:  M Cimbollek; B Nies; R Wenz; J Kreuter
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

3.  Inconsistency of synergy between the beta-lactamase inhibitor CP-45,899 and beta-lactam antibiotics against multiply drug-resistant Enterobacteriaceae and pseudomonas species.

Authors:  R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

4.  Treatment of infections caused by ampicillin-resistant pathogens with a combination of ampicillin and CP-45,899.

Authors:  J F Plouffe
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

5.  Susceptibilities of gram-negative bacteria to combinations of antimicrobial agents in vitro.

Authors:  B Leng; B R Meyers; S Z Hirschman; G T Keusch
Journal:  Antimicrob Agents Chemother       Date:  1975-08       Impact factor: 5.191

6.  Effect of clindamycin on the in vitro activity of amikacin and gentamicin against gram-negative bacilli.

Authors:  S H Zinner; R B Provonchee; K S Elias; G Peter
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

7.  Effect of clindamycin on aminoglycoside activity in a murine model of invasive Escherichia coli infection.

Authors:  E Ekwo; G Peter
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

8.  In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

9.  Synergism between penicillin, clindamycin, or metronidazole and gentamicin against species of the Bacteroides melaninogenicus and Bacteroides fragilis groups.

Authors:  I Brook; J C Coolbaugh; R I Walker; E Weiss
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

10.  In vitro activity of gentamicin and minocycline alone and in combination against bacteria associated with intra-abdominal sepsis.

Authors:  R J Fass; D E Ruiz; R B Prior; R L Perkins
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.